Background: The incidence of hospitalized rhabdomyolysis is not well characterized among patients taking statin-fibrate combination therapies. OBJECTIVE: To estimate and compare the rates of ...

We identified 1,116,805 statin and/or fibrate initiators who met eligibility criteria from January 1, 1998, through December 31, 2007. Of these, 86.6% were statin initiators, 12.9% were fibrate ...